AAPLOG Statement on the 5th Circuit Court of Appeals Ruling on AHM v FDA

Today is a victory for our patients. Since the drugs Mifepristone and Misoprostol were approved for use in chemical abortions in 2000, the FDA has repeatedly removed necessary safeguards meant to decrease the risk of serious harm to the women who consume them. Today’s 5th Circuit Court of Appeals order reinstating these safeguards for Mifepristone is a first step towards reprioritizing women’s health over the interests of the abortion industry and its allies within our profession. As medical professionals, we will continue to fight for all our patients to be able to receive fully informed consent and the best evidence-based healthcare possible.